← All ABPANC Flashcard Decks

ABPANC Anesthesia Recovery & Phase Management Flashcards

6 cards from real ABPANC practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.

Read the first 6 ABPANC Anesthesia Recovery & Phase Management flashcards as text
  1. In PACU Phase I, what is the primary nursing priority when admitting a patient from the OR?

    Answer: Establish airway patency and assess respiratory status

    Airway patency and respiratory assessment are the highest priorities upon PACU Phase I admission to prevent hypoxia.

  2. Which Aldrete score criterion assesses a patient's readiness to be discharged from PACU Phase I to Phase II?

    Answer: SpO2 ≥92% on room air or baseline O2

    An Aldrete score of ≥9, including adequate oxygen saturation, indicates readiness for Phase II discharge.

  3. A patient in PACU develops laryngospasm post-extubation. What is the immediate nursing intervention?

    Answer: Apply jaw thrust and positive pressure ventilation with 100% O2

    Jaw thrust and positive pressure ventilation with 100% oxygen is the initial intervention to break laryngospasm.

  4. Which phase of perianesthesia care involves preparing the patient for discharge to home or a care unit with ongoing monitoring?

    Answer: PACU Phase II

    PACU Phase II focuses on preparing the patient for discharge home or to an inpatient unit with less intensive monitoring.

  5. What is the most common cause of post-operative hypoxemia in the immediate PACU period?

    Answer: Residual anesthetic-induced respiratory depression

    Residual effects of anesthetic agents are the most common cause of respiratory depression and hypoxemia in the immediate post-operative period.

  6. During PACU recovery, a patient exhibits signs of malignant hyperthermia. Which medication is the definitive treatment?

    Answer: Dantrolene sodium IV

    Dantrolene sodium inhibits calcium release from the sarcoplasmic reticulum and is the definitive pharmacologic treatment for malignant hyperthermia.